CLINICAL ROLE -
Trending News Today: Support for the ACA Hits All-Time High
Top news of the day from across the health care landscape.
Read More
Trending News Today: Importance of Real-World Evidence Continues to Grow
New Model Predicts Immunotherapy Resistance
Accounting for potential drug resistance improve the treatment of cancer.
Trending News Today: Indiana Medicaid Work Requirement Approved
Amino Acid Common in Energy Drinks May Boost Potency of Multiple Sclerosis Drugs
Taurine may increase the remyelination effects of multiple sclerosis treatments.
Missed Clinical Opportunities Perpetuate Low HPV Vaccination Rate
Two-thirds of young women experienced at least 1 missed opportunity to receive the human papilloma virus vaccine.
Exercise Shrinks Cancer Mortality Rate for Patients with Heart Disease
Physically fit patients with coronary artery disease were nearly half as likely to die from cancer.
Trending News Today: 8.7 Million Americans Enrolled in Affordable Care Act Plans for 2018
Trending News Today: Disparities Exist for Patients with Sickle Cell Disease
FDA Updates Tasigna Label to Reflect Treatment-Free Remission in Leukemia
Nilotinib (Tasigna) label includes information for patients with chronic myeloid leukemia who may stop treatment after achieving remission.
FDA Clears Noninvasive Stereotactic Radiotherapy System for Breast Cancer
GammaPod system can accurately deliver radiation therapy to breast tumors.
Top 5 Most Read Articles of 2017
The most popular articles of the year from The American Journal of Pharmacy Benefits.
A look back at the top articles of the year on Specialty Pharmacy Times.
Drug Cost Increases May Threaten Patient Access
The list price for 768 drugs commonly used by seniors increased by 6.4% in 2015
Investigational Drug Improves Efficacy of Aggressive Lymphoma Treatment
Polatuzumab vedotin plus bendamustine and rituximab increased complete response rates to 40% among patients with diffuse large B-cell lymphoma.
Top 5 FDA Drug Approvals of 2017
The most read FDA approval articles on The American Journal of Pharmacy Benefits.
Top 5 FDA Approvals of Specialty Drugs in 2017
A look at the most read drug approval articles of 2017 covered by Specialty Pharmacy Times.
Cure for Diabetes in Sight
Immunotherapy may reverse type 1 diabetes.
Nearly Half of Cancers, Related Deaths Are Preventable
Cigarette smoking played a role in 19% of cancers and 29% of cancer-related deaths in 2014.
Top 5 Most Watched Videos in 2017
A look at the most popular videos on The American Journal of Pharmacy Benefits over the past year.
DIR Fee Controversy Shaping the Future of Pharmacy
A look back at the debate around direct and indirect remuneration fees in 2017.
Fighting HIV, Other Viruses Could Trigger Cancer Mutations
Enzymes that protect the immune system may malfunction and provoke cancer-related mutations.
Top 5 PBM Articles of 2017
A look at the most-read pharmacy benefit manager articles published on The American Journal of Pharmacy Benefits in 2017.
Top 10 Most Watched SPT Videos of 2017
A review of the most popular video interviews on Specialty Pharmacy Times.
Immunotherapy Combination Effective Against Chemotherapy-Resistant Breast Cancer
Pembrolizumab plus trastuzumab may overcome drug-resistance among patients with advanced HER2+ breast cancer.
Multiple Sclerosis Drug Market Projected to Boom
The market for disease-modifying multiple sclerosis drugs is projected to reach $25.3 billion by 2026, according to a new report.
Trending News Today: 2018 ACA Sign-Ups Nearly Match 2017 Numbers
Trending News Today: Antitrust Suit Filed Against Biologic Manufacturer Over Biosimilar Practices
Nanoparticle Delivery of Cancer Drugs Effective in Endometrial Cancer
Paclitaxel plus nintedanib overcomes chemotherapy-resistance in endometrial cancer.
Glioblastoma Survival Technique Provides Clues to New Treatment Strategy
Inhibiting a protein kinase may improve the efficacy of radiation in glioblastoma.